February 23rd 2023
February 23rd 2023
Radiation Therapy Updates for Breast Cancer in the NCCN Guidelines
March 24th 2017On the second day of the 22nd Annual Conference of the National Comprehensive Cancer Network (NCCN), Kilian E. Salerno, MD, of the Roswell Park Cancer Institute, walked the audience through updates to the NCCN Guidelines, explaining clinical situations in which radiation is indicated, appropriate targets of radiation treatment, and optimal approaches for minimizing toxicity.
Read More
Doctors Who Consult Online Drug Database Quicker to Prescribe New Generics
March 20th 2017A new study has found that clinicians who used an electronic drug reference database at the point of care tended to prescribe a more varied range of medications and started to prescribe new generic drugs faster than other doctors.
Read More
A Framework for Assessing the Value of Rare Disease Treatments
March 16th 2017Difficulty in making pricing and reimbursement decisions for rare diseases has prevented patients from having universal access to new medicines despite increased investment in their research and development. In Europe, a group has proposed 9 principles to guide value assessment, pricing, and funding.
Read More
Ribociclib Approved as Front-Line Therapy for HR+/HER2- Breast Cancer
March 13th 2017The FDA has approved Novartis’ ribociclib (Kisqali) for treatment of postmenopausal women with hormone receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) advanced or metastatic breast cancer.
Read More
Improving Value Frameworks and Guiding Them to Maturity
March 10th 2017With costs of care being more closely scrutinized, there has been a proliferation of value frameworks to help guide decision making for treatments. In a blog post for Health Affairs, Robert W. Dubois, MD, PhD, and Kimberly Westrich, MA, both of the National Pharmaceutical Council, provide possible considerations for advancing the field of value frameworks.
Read More
Bundled Payments and Other Cost-Management Approaches to Oncology Care
February 22nd 2017At the 5th annual Patient-Centered Oncology Care® meeting, stakeholders shared their views on how bundled payments, clinical pathways, and other value-based approaches can be implemented in cancer care while ensuring adequate care quality.
Read More
Survey Finds Varied Views on Value of Multiple Sclerosis Therapies
February 21st 2017Population-level judgements on the value of therapies to treat multiple sclerosis don’t adequately depict the differences between how providers and payers view value compared with patients and how patients view value different from one another.
Read More
ASCO Framework Can Help Providers Assess Clinical Pathway Programs
November 29th 2016The American Society of Clinical Oncology (ASCO) has released the Criteria for High-Quality Clinical Pathways in Oncology, which is expected to help providers assess the quality, utility, and integrity of pathway programs in the United States.
Read More